T835-2241 Screening compound: N~1~-(3-chloro-2-methylphenyl)-3-{[3-(2-methoxyethyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}-1-pyrrolidinecarboxamide

T835-2241 Screening compound: N~1~-(3-chloro-2-methylphenyl)-3-{[3-(2-methoxyethyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}-1-pyrrolidinecarboxamide
T835-2241 Screening compound: N~1~-(3-chloro-2-methylphenyl)-3-{[3-(2-methoxyethyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}-1-pyrrolidinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T835-2241
N~1~-(3-chloro-2-methylphenyl)-3-{[3-(2-methoxyethyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}-1-pyrrolidinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T835-2241

Molecular Formula

C22H26ClN5O2 (C22 H26 ClN5 O2)

Compound Name

N~1~-(3-chloro-2-methylphenyl)-3-{[3-(2-methoxyethyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}-1-pyrrolidinecarboxamide

IUPAC name

N-(3-chloro-2-methylphenyl)-3-{[3-(2-methoxyethyl)-3H-imidazo[45-b]pyridin-2-yl]methyl}pyrrolidine-1-carboxamide

SMILES

Cc(c(NC(N1CC(Cc(n2CCOC)nc3c2nccc3)CC1)=O)ccc1)c1Cl

InChI

InChI=1S/C22H26ClN5O2/c1-15-17(23)5-3-6-18(15)26-22(29)27-10-8-16(14-27)13-20-25-19-7-4-9-24-21(19)28(20)11-12-30-2/h3-7,9,16H,8,10-14H2,1-2H3,(H,26,29)/t16-/m0/s1

InChI Key

AETCRCDXOXGRFZ-INIZCTEOSA-N

MDL Number (MFCD)

MFCD28121610

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

427.93

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.052

Distribution Coefficient, logD

4.052

Water Solubility, LogSw

-4.15

Polar Surface Area

54.441

Acid Dissociation Constant (pKa)

11.91

Base Dissociation Constant (pKb)

3.35

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.91

T835-2241 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T835-2241 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T835-2241?
Check Price and Availability of T835-2241, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T835-2241 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T835-2241
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T835-2241
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T835-2241 available by request